NEW YORK (AP) — Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his 30s to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame.
A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising — the habits behind many commercial diet plans and decades of conventional wisdom on sustainable weight loss.
Yet Jobling’s experience also has altered his perspective on dieting. He now sees obesity as a disease that requires medical intervention, not just behavioral changes. In fact, he thinks he will need to stay on a drug like Wegovy for the rest of his life even though it has taken some of the joy out of eating.
Related articles:
Related suggestion:
The past continues to shape our futureExhibiting a timeless eleganceXi delivers speech at Spring Festival reception, extending festive greetings to all ChineseXi Focus: Xi's Shanghai Inspection Tour Sends Signal of HighLiving in a world of love like never beforeAsia's manufacturing PMI rebounds to 50.4Xi Focus: China's Leadership Holds Symposium for Soliciting Advice on Economic WorkChina's homegrown C919 jetliner flies to Singapore for airshowInternational experts expect the Chinese economy to flourish with more technological breakthroughsA drink heritage to cherish
2.8789s , 6515.1875 kb
Copyright © 2024 Powered by What do weight loss drugs mean for a diet industry built on eating less and exercising more? ,Stellar Stories news portal